参考文献/References:
［1］Kitagawa R, Nakanishi T, Fukaya T, et al. Current topics and perspective of chemotherapy for uterine cervical cancer ［J］. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 2017, 44(2): 126-130.
［2］Krishnan S, Dhillon P K, Bhadelia A A, et al. Report from a symposium on catalyzing primary and secondary prevention of cancer in India ［J］. Cancer Causes & Control, 2015, 26(11): 1671-1684.
［3］Hariri S, Nancg MB,Linda M N,et al.R-eduction in HPV 16/18 associated high grade cervical lesions following HPV vaccine introduction in the United States ［J］. Vaccine, 2016, 31(2): 201.
［4］Chan PK，Lam CW，Cheung TH,et al.Association of human papillomavirus type 58 variant with the risk of cervical cancer ［J］．J Natl Cancer Inst，2002,94(16)：1249-1253.
［5］Clifford G M, Smith J S, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide:a meta-analysis ［J］. British Journal of Cancer, 2003,88(1): 63-73.
［6］温金锁，戚玉琴，姚乐毅，等．宝鸡市恶性肿瘤流行趋势分析 ［J］．中华疾病控制杂志，2012，16（10）：839-841．
［7］董航，刘华章，林国桢，等．广州市2000-2011年宫颈癌发病趋势及年龄分布特征 ［J］．中华疾病控制杂志，2015，19（5）：451-
453, 480．
［8］裴蕴锋，经先振，周娟，等．医院就诊人群HPV感染的流行病学特征及其与宫颈癌/癌前病变的关系 ［J］．华中科技大学学报，2018，3（47）：349-350．
［9］Qian Lili, Zhang Yu, Cui Dawei, et al. Analysis of epidemiological trends in human papillomavirus infection among gynaecological outpatients in Hangzhou, China, 2011-2015 ［J］. BMC Infectious Diseases, 2017, 17(1): 393-401.
［10］Holt H L, Zhao F-h. Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China ［J］. International Journal of Cancer, 2017, 140(3): 544-554.
［11］张佳立，郜红艺，张江宇，等．HPV多重感染与宫颈癌及癌前病变发生、发展的关系研究 ［J］．中国妇幼保健，2010，25（23）：3270-3274．
［12］陶志梅，潘敏，俞美娟，等．高危型人乳头瘤病毒感染联合液基薄层细胞检测对宫颈癌及宫颈癌前病变筛查与随访的临床意义 ［J］．中华医院感染学杂志，2015，20（6）：635-639．
［13］Ryu KJ, Lee S, Min KJ, et al.Reflex human papillomavirus test results as an option for the management of korean women with atypical squamous cells cannot exclude high-grade squamous intraepithelial Lesion ［J］.Oncologist,2015,20(6):635-639.
［14］Lee S, Kim JW, Hong JH, et al. Clinical significance of HPV DNA cotesting in Korean women with ASCUS or ASC-H ［J］. Diagn Cytopathol, 2014,42(12):1058-1062.
［15］蒋洪波，杨龙涛，周红荣．三种方法在子宫颈癌及癌前病变筛查中的价值比较 ［J］．陕西医学杂志，2019，2（48）：451-453．
［16］Iftner T, Becker S, Neis K J, et al. Head-to-head comparison of the RNA-Based aptima human papillomavirus (HPV) assay and the DNA-Based hybrid capture 2 HPV test in a routine screening population of women aged 30 to 60 years in Germany ［J］. Journal of Clinical Microbiology, 2015, 53(8):2509-2516.
［17］Burger E A, Kornr H, Klemp M, et al. HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review ［J］. Gynecologic Oncology, 2011, 120(3): 430-438.
［18］Benevolo M，Vocaturo A，Caraceni D，et al. Sensitivity，specificity and clinical value of human papillomavirus（HPV）E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test ［J］. J Clin Microbiol，2011，49（7）：2643-2650.
［19］聂小倩，张维娜，张盛苗，等．人乳头瘤病毒E 6/E 7 信使核糖核酸表达与宫颈病变病理级别相关性分析 ［J］．中国计划生育和妇产科，2018，10（4）：40-44．
［20］Ronco G, Giorgi-Rossi P, Carozzi F, et al. New technologies for cervical Cancer screening (NTCC) working group: Efficacy of human papillomavirus testing for the detection of invasive cervical cancer and cervical intraepithelial neoplasia: A randomised controlled trial ［J］. Lancet Oncol, 2010,11:249-257.
［21］Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guideline ［J］. Obstet Gynecol,2015,136(2):178-182.
［22］Ma Li, Cong Xiao, Shi Mai, et al. Distribution of human papillomavirus genotypes in cervical lesions ［J］. Experimental and Therapeutic Medicine, 2017, 13(2): 535-541.
［23］苗野，阮强，马艳萍．不同人乳头瘤病毒亚型感染与宫颈病变的相关性 ［J］．中国医科大学学报，2019，48（7）：606-614．
［24］Sun Zhengrong, Zhang Rong, Liu Zhonghua, et al. Development of a fluorescence-based multiplex genotyping method for simultaneous determination of human papillomavirus infections and viral loads ［J］. BMC Cancer, 2015, 15(6): 860-870.
［25］李博涵，谭桂春，曲芃芃．高危型人乳头瘤病毒阳性患者宫颈病变风险预测方法及进展［J］．国际妇产科学杂志，2019，1（46）：98-100．
［26］Wang Wei, Zhang Xian-hui, Li Mei, et al. Association between viral loads of different oncogenic human papillomavirus types and the degree of cervical lesions in the progression of cervical Cancer ［J］. Clinica Chimica Acta, 2018, 483(2018）: 249-255.
［27］Wu Z, Qin Yu, Yu Lu-lu, et al. Association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: results from a large-scale cross-sectional study［J］. Journal of Medical Virology, 2017, 89(3): 535-541.
相似文献/References:
[1]帅翰林,罗新.射频消融技术在治疗宫颈病变和宫颈人乳头瘤病毒感染中的作用[J].中国计划生育和妇产科,2013,(01):0.
SHUAI Han-lin,LUO Xin.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[2]钟茜,赵霞.宫颈癌诊治中的过度治疗与治疗不足[J].中国计划生育和妇产科,2013,(02):0.
ZHONG Xi,ZHAO Xia,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[3]罗新,范瑾.hTERC基因检测技术在宫颈病变筛查中的地位[J].中国计划生育和妇产科,2013,(03):0.
LUO Xin,FAN Jin.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[4]吴晓菁,谈军,李优云,等.广州市白云区流动人口育龄妇女HPV感染及宫颈病变的流行病学调查[J].中国计划生育和妇产科,2013,(03):0.
WU Xiao - jing,TAN Jun,LI You - yun,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[5]代鸣,邹志梅,黄江平,等.九江地区9328例宫颈液基细胞学检查结果分析[J].中国计划生育和妇产科,2014,(01):0.
DAI Ming,ZOU Zhi-mei,HUANG Jiang-ping,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[6]朱书力,李力.树突状细胞对宫颈癌作用的研究进展[J].中国计划生育和妇产科,2014,(03):0.
[7]朱木华,林彩菊,叶淑英,等.广东省惠州地区流动人口育龄妇女人乳头瘤病毒感染及宫颈病变的流行病学调查[J].中国计划生育和妇产科,2014,(06):0.
ZHU Mu-hua,LIN CAI-ju,YE Shu-ying,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[8]贾艳艳,陈志龙,史惠蓉,等.人乳头瘤病毒L1蛋白在宫颈病变中的表达及其意义[J].中国计划生育和妇产科,2014,(06):0.
JIA Yan-yan,CHEN Zhi-long,SHI Hui-rong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[9]姜志欣,吴玉璘.女性人乳头瘤病毒感染及相关肿瘤[J].中国计划生育和妇产科,2014,(07):0.
[10]孙肖霞,王志莲,郝敏,等.胰岛素样生长因子轴与宫颈癌的相关性研究[J].中国计划生育和妇产科,2015,(05):0.